皮肤安全型穴位贴敷方治疗轻型新型冠状病毒肺炎的临床观察

Clinical Observation on the Treatment of Mild Novel Coronavirus Pneumonia with Skin Safe Acupoint Application Formula

摘要: 目的：回顾性分析皮肤安全型穴位贴敷方治疗轻型新型冠状病毒肺炎的疗效和安全性。方法：选择轻型新型冠状病毒肺炎口服药物治疗后症状仍加重的患者，在原有药物的基础上给予皮肤安全型穴位贴敷方穴位贴敷治疗，取穴为合谷、大椎、天突，疗程为1天。观察患者治疗前后症状的变化和相关不良反应发生情况。结果：1) 治疗后，鼻塞：有效5例，无效2例，有效率71.4%；发热：有效4例，无效1例，有效率80%；乏力：有效3例，无效2例，有效率60%；腹泻：有效6例，无效1例，有效率85.7%；咳嗽：有效9例，无效6例，有效率60%；咳痰：有效13例，无效4例，有效率76.5%；肌痛：有效4例，无效2例，有效率66.7%；结膜炎：有效5例，无效2例，有效率71.4%；流涕：有效9例，无效1例，有效率90%；味觉减退：有效2例，无效1例，有效率66.7%；嗅觉减退：有效2例，无效1例，有效率66.7%；咽痛：有效9例，无效5例，有效率64.3%；2) 研究过程中，观察组出现4例轻微皮肤症状，均为敷贴材料所致。结论：皮肤安全型穴位贴敷方穴位贴敷治疗轻型新型冠状病毒肺炎安全有效。

Abstract: Objective: To retrospectively analyze the efficacy and safety of skin safe acupoint application in the treatment of mild novel coronavirus pneumonia. Methods: Select patients with mild novel coronavirus pneumonia whose symptoms are still aggravated after oral drug treatment. On the basis of the original drugs, give skin safe acupoint application formula acupoint application treatment. The acupoints are Hegu, Dazhui and Tiantu, and the course of treatment is 1 day. The changes of symptoms and the occurrence of related adverse reactions were observed before and after treatment. Results: 1) after treatment, nasal congestion: 5 cases were effective, 2 cases were ineffective, and the effective rate was 71.4%; Fever: 4 cases were effective, 1 case was ineffective, and the effective rate was 80%; Asthenia: 3 cases were effective, 2 cases were ineffective, and the effective rate was 60%; Diarrhea: 6 cases were effective, 1 case was ineffective, and the effective rate was 85.7%; Cough: 9 cases were effective, 6 cases were ineffective, and the effective rate was 60%; Expectoration: 13 cases were effective, 4 cases were ineffective, and the effective rate was 76.5%; Myalgia: 4 cases were effective, 2 cases were ineffective, and the effective rate was 66.7%; Conjunctivitis: 5 cases were effective, 2 cases were ineffective, and the effective rate was 71.4%; Runny nose: 9 cases were effective, 1 case was ineffective, and the effective rate was 90%; Hypoesthesia: 2 cases were effective, 1 case was ineffective, and the effective rate was 66.7%; Anosmia: 2 cases were effective, 1 case was ineffective, and the effective rate was 66.7%; Pharyngeal pain: 9 cases were effective, 5 cases were ineffective, and the effective rate was 64.3%; 2) During the study, 4 cases of mild skin symptoms in the observation group were caused by the application materials. Conclusion: Skin safe acupoint application formula is safe and effective in the treatment of light novel coronavirus pneumonia.